ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,060Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 198

$682K Total Retail Price of All Prescriptions

Rank: 33 out of 198

658 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 658 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 658 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 14,384 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
AMLODIPINE BESYLATE 748 721 1 4
LEVOTHYROXINE SODIUM 677 657 2 1
SIMVASTATIN 659 632 3 2
LISINOPRIL 638 627 4 6
OMEPRAZOLE 524 505 5 3
WARFARIN SODIUM 504 502 6 7
POTASSIUM CHLORIDE 493 475 7 9
FUROSEMIDE 396 379 8 5
ATORVASTATIN CALCIUM 373 363 9 12
LOSARTAN POTASSIUM 316 306 10 18
PRAVASTATIN SODIUM 291 276 11 19
ALENDRONATE SODIUM 249 243 12 21
ATENOLOL 245 242 13 17
SERTRALINE HCL 239 235 14 25
METOPROLOL TARTRATE 230 218 15 10
CITALOPRAM HBR 225 209 16 20
TRAMADOL HCL 221 199 17 15
METOPROLOL SUCCINATE 220 212 18 11
HYDROCODONE-ACETAMINOPHEN 202 166 S3 19 8
TAMSULOSIN HCL 195 184 20 27
METFORMIN HCL 189 185 21 13
ZETIA 177 168 22 68
GLIMEPIRIDE 169 168 23 35
DONEPEZIL HCL 166 162 24 28
HYDROCHLOROTHIAZIDE 161 161 25 16
ZOLPIDEM TARTRATE 161 161 25 22
FENOFIBRATE 127 117 27 61
CRESTOR 122 116 28 26
ESCITALOPRAM OXALATE 115 110 29 53
SYNTHROID 111 109 30 36
ALLOPURINOL 110 110 31 23
TRIAMTERENE-HCTZ 107 107 32 32
DIOVAN 102 102 33 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 94 34 38
GABAPENTIN 97 77 35 14
NEXIUM 93 85 36 40
CYMBALTA 90 76 37 48
CARVEDILOL 87 87 38 24
BISOPROLOL FUMARATE 86 85 39 87
BISOPROLOL-HYDROCHLOROTHIAZIDE 83 79 40 127
ROPINIROLE HCL 81 69 41 74
CIPROFLOXACIN HCL 78 77 42 55
FLUTICASONE PROPIONATE 77 75 43 39
CLOPIDOGREL 73 73 44 42
MELOXICAM 72 67 45 30
AZITHROMYCIN 70 65 46 56
FINASTERIDE 69 69 47 94
LOSARTAN-HYDROCHLOROTHIAZIDE 68 68 48 49
CARBIDOPA-LEVODOPA 67 67 49 71
QUINAPRIL HCL 65 65 50 145
PHENYTOIN SODIUM EXTENDED 64 64 51 141
DOXAZOSIN MESYLATE 61 61 52 96
PROPRANOLOL HCL 60 60 53 92
LEVOFLOXACIN 59 54 54 81
VYTORIN 59 59 54 145
TRICOR 56 56 56 93
KLOR-CON M20 55 51 57 137
FAMOTIDINE 54 43 58 57
RAMIPRIL 54 54 58 72
RISPERIDONE 53 50 60 82
FOSINOPRIL SODIUM 50 50 61 156
PANTOPRAZOLE SODIUM 50 43 61 31
CLOTRIMAZOLE-BETAMETHASONE 50 50 61 205
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 26, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.